reference/26999420

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26999420

Outgoing Links

Predicate	Object
contentType	Case Reports\|Letter\|Research Support, Non-U.S. Gov't
endingPage	1755
issn	0091-6749
issueIdentifier	6
pageRange	1752-1755
publicationName	The Journal of allergy and clinical immunology
startingPage	1752
bibliographicCitation	Frémond M, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, Bessis D, Cros G, Rice GI, Charbit B, Hulin A, Khoudour N, Caballero CM, Bodemer C, Fabre M, Berteloot L, Le Bourgeois M, Reix P, Walzer T, Moshous D, Blanche S, Fischer A, Bader-Meunier B, Rieux-Laucat F, Crow YJ, Neven B. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children. Journal of Allergy and Clinical Immunology. 2016 Dec;138(6):1752–5. doi: 10.1016/j.jaci.2016.07.015.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2274c27f632915f5d11cdba4afc4f787 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70324ba69b1422bf9b03c7ce0c7a08ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4902-5332 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0318-3044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c6c98e0389865816b00b97f960bf630 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2be3b79374860aec56eb25e1be1439c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef24be8b09eef7220ea8a0626e67ac3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d71d4327cb04a9802545c651fc6ea79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55eb2715bb0bcb35eac9c4588b4c5e85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9f85baec712d01c0b5e1d5914be0c8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1aff3fe12b0a1540cc2485d65cbbf49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3254cee3879e145ce699396aadfedede http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79bdd38eafee8b9e37080359dae98b64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67fa2fb34af106a67127eb7eecd99d06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03de18a058a498ea67759fd73d9bc07f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2449f6485148cfd5e456a0e039145d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9681-3142 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16389876b892222c2e09eb447474a7e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8476-8196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c9d8827f9fc30b239a578695750cf2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b63a2ff5949444587c66f5b7000ebed1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcceca742aec9c6caff6bb84086cd405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae7c4531206c3bc27f3ed51df1c53f41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c88ddcb6e6e8200041fa0fd0944b8e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e105aadbbaf9edfa834ad6875f151f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b734728a3cff62cf290746298556516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07287767f7cfd45f81d565e6acd2de95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef4211203ce17bcde5b77df96b0c83e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_779711b6b68573c9a3a0c5adeba65233
date	201612
identifier	https://doi.org/10.1016/j.jaci.2016.07.015 https://pubmed.ncbi.nlm.nih.gov/27554814
isPartOf	https://portal.issn.org/resource/ISSN/0091-6749 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4431
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
discusses	http://id.nlm.nih.gov/mesh/M0203027 http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0013341 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0526634 http://id.nlm.nih.gov/mesh/M0473764 http://id.nlm.nih.gov/mesh/M0473784 http://id.nlm.nih.gov/mesh/M0549299 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D008565Q000235 http://id.nlm.nih.gov/mesh/D053613Q000037 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D053614Q000037 http://id.nlm.nih.gov/mesh/D011720Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D011743 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D053613Q000235 http://id.nlm.nih.gov/mesh/D002648
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9587 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_01200ab2a8db50265b8eee3c8ef09523 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_335366b86eab13ea9f6925279dca28aa http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25126798 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_36693afeede0232c498f02f72b72526d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3717 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3716 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID340061

Total number of triples: 81.